| 1 |
26712905 | Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial. | 2016 Apr |
1 |
| 2 |
25514117 | Antitumor Effect of Docetaxel in Osteosarcoma by the Inhibition of Wnt Signal Channel. | 2015 Nov |
1 |
| 3 |
24193570 | Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients. | 2014 Feb |
3 |
| 4 |
21634054 | Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment. | 2011 Jan |
1 |
| 5 |
20106511 | Docetaxel, carboplatin and 5-fluorouracil (TCF) chemotherapy in patients with unresectable metastatic carcinoma of cervix. | 2010 Apr |
3 |
| 6 |
20437857 | Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen. | 2010 Jan-Feb |
1 |
| 7 |
17876342 | PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients. | 2008 Apr |
3 |
| 8 |
16924496 | A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer. | 2007 Apr |
2 |
| 9 |
17664469 | Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. | 2007 Aug 1 |
1 |